Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SomnoMed Limited Announces Renew Sleep Solutions Opens First Two Centres in Q2 (ASX:SOM)

23rd January 2017, SomnoMed Limited (ASX:SOM) announced that its subsidiary Renew Sleep Solutions, Inc. (“RSS”), formerly Sleep Centres America, Inc. treated its first patients in its firs...read more

SomnoMed Limited, Appendix 4C (ASX:SOM)

Quarterly report for entities subject to Listing Rule 4.7B Quarter ended: 31 December 2016 To view Report please download PDF attached:

SomnoMed, Chairman’s Address Delivered at Annual General Meeting 24th November 2016 (ASX:SOM)

The 2015/16 financial year was another successful year for our company. Our revenues grew by 29% to $44 million and 59,000 devices were sold during the year. Direct sales for the year grew by 22.6%, w...read more

SomnoMed Announces Sales Growth Accelerating as Northern Half Returns from Summer Holidays (ASX:SOM)

18th October 2016, SomnoMed Limited (ASX:SOM) announced today record breaking September sales (+23.8% year on year) compensated for the usually soft Northern summer months of July and August (+13.0% y...read more

SomnoMed Limited, Preliminary Final Report – 30 June 2016 (ASX:SOM)

Contents Results for announcement to the Market Preliminary Consolidated Statement of Profit or Loss and Other Comprehensive Income Preliminary Consolidated Statement of Financial Position ...read more

SomnoMed Investor Presentation Financial Year 2015-16 (ASX:SOM)

Main Achievements in 2015/16 - Direct global growth in volume accelerated in 2015/16, net average sales price improved, device GM improved, underlying EBITDA increased by 141% - SomnoMed now ope...read more

Strong finish to the financial year for SomnoMed (ASX:SOM)

21st July 2016, SomnoMed Limited (ASX:SOM) announced today that continuing strong Q4 growth in direct sales volume allowed it to generate unaudited quarterly group revenues of $11.6 million (+ 28.6%) ...read more

Derek Smith appointed Global CEO of SomnoMed (ASX:SOM)

The board of SomnoMed Limited (ASX:SOM) is pleased to announce the appointment of Derek Smith as new global CEO from 1 September 2016. The appointment followed an extensive search and evaluation of ca...read more

SomnoMed Announces CEO Appointed for New Direct to Patient Business Entity (ASX:SOM)

27thJune 2016, SomnoMed Limited (ASX:SOM) announced today the appointment of James (Jim) R. Evanger MBA BA as President and CEO of its recently formed subsidiary – Sleep Centres America, Inc. (&...read more

SomnoMed announces Retail Entitlement Offer (ASX:SOM)

Dear SomnoMed Shareholder SomnoMed Limited (“SomnoMed” or the “Company”) is pursuing an exciting new growth opportunity, involving the rollout of a network of US bas...read more

SomnoMed announces Results of Institutional Entitlement Offer (ASX:SOM)

SomnoMed is today pleased to announce the successful completion of the Institutional Entitlement Offer, which was oversubscribed. Under the Institutional Entitlement Offer 1,613,983 New Shares will...read more

SomnoMed announces Investor Presentation (ASX:SOM)

SomnoMed announces Investor Presentation Sleep Centres America Inc. and Pro rata accelerated entitlement issue. For further information, please download pdf attached:

SomnoMed announces Chairman’s Letter (ASX:SOM)

SomnoMed Limited (“SomnoMed” or the “Company”) is pursuing an exciting new growth opportunity, involving the rollout of a network of US based treatment centres which will pr...read more

SomnoMed Announces Continuing High Growth in the Third Quarter (ASX:SOM)

20th April 2016, SomnoMed Limited (ASX:SOM) announced that continuing high growth in its volume of sales of its sleep apnea devices resulted in it recording a growth of 28% of its sleep apnea devic...read more

SomnoMed Investor Presentation - Half Year Review Financial Year 2015-2016 (ASX:SOM)

Global highlights first half 2015/16 - Direct sales volumes +28.8% and group revenues +30.2% - MAS gross margin maintained at 68.5% and Group gross margin ...read more

Viewing: 16 - 30 of 58 Previous | Next